The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Stamoulis Christiana since year 2005.
The trader's CIK number is 1502917.
At the time of the last reporting, Stamoulis Christiana was the SVP, Corp Strategy & Bus Devlp of Hologic Inc .
(stock ticker symbol HOLX).
See this page for all insider trading activities at Hologic Inc .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2018-11-28 | HOLX | Hologic Inc | Option Ex | 13,257 | 17.51 | 232,130 |
| 2018-11-28 | HOLX | Hologic Inc | Sale | 13,257 | 44.50 | 589,949 |
| 2018-10-02 | HOLX | Hologic Inc | Sale | 30,967 | 40.70 | 1,260,480 |
| 2018-10-02 | HOLX | Hologic Inc | Option Ex | 30,967 | 15.29 | 473,485 |
| 2017-03-08 | HOLX | Hologic Inc | Option Ex | 2,427 | .00 | 0 |
| 2016-01-01 | HOLX | Hologic Inc | Option Ex | 3,272 | .00 | 0 |
| 2015-01-01 | HOLX | Hologic Inc | Option Ex | 3,914 | 26.74 | 104,660 |
| 2013-07-15 | VRTX | Vertex Pharmaceuticals Inc / Ma | Option Ex | 1,125 | 33.82 | 38,047 |
| 2013-07-15 | VRTX | Vertex Pharmaceuticals Inc / Ma | Sale | 1,125 | 86.79 | 97,638 |
| 2013-07-05 | VRTX | Vertex Pharmaceuticals Inc / Ma | Sale | 4,687 | 81.03 | 379,811 |
| 2013-07-05 | VRTX | Vertex Pharmaceuticals Inc / Ma | Option Ex | 4,687 | 34.57 | 162,029 |
| 2013-05-15 | VRTX | Vertex Pharmaceuticals Inc / Ma | Sale | 602 | 79.99 | 48,153 |
| 2013-04-29 | VRTX | Vertex Pharmaceuticals Inc / Ma | Option Ex | 77,999 | 34.20 | 2,667,175 |
| 2013-04-30 | VRTX | Vertex Pharmaceuticals Inc / Ma | Option Ex | 1 | 34.57 | 34 |
| 2013-04-29 | VRTX | Vertex Pharmaceuticals Inc / Ma | Sale | 82,999 | 79.39 | 6,588,875 |
| 2013-04-30 | VRTX | Vertex Pharmaceuticals Inc / Ma | Sale | 1 | 77.88 | 77 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stamoulis Christiana (SVP, Corp Strategy & Bus Devlp of Hologic Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.